Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis
Publication
, Conference
Bylsma, L; Nielson, CM; Fryzek, J; Saad, H; Crawford, J
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
August 2021
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
August 2021
Volume
30
Start / End Page
111 / 111
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bylsma, L., Nielson, C. M., Fryzek, J., Saad, H., & Crawford, J. (2021). Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 30, pp. 111–111).
Bylsma, Lauren, Carrie M. Nielson, Jon Fryzek, Hossam Saad, and Jeffrey Crawford. “Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 30:111–111, 2021.
Bylsma L, Nielson CM, Fryzek J, Saad H, Crawford J. Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021. p. 111–111.
Bylsma, Lauren, et al. “Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 30, 2021, pp. 111–111.
Bylsma L, Nielson CM, Fryzek J, Saad H, Crawford J. Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021. p. 111–111.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
August 2021
Volume
30
Start / End Page
111 / 111
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences